Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC
Clinical trial NCT00356941 · TERMINATED
Trial details
- NCT number
- NCT00356941
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2007-05-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.